Determination of vhl Gene Mutations in Sporadic Renal Cell Carcinoma

Landis, 1999, Cancer statistics: 1999, CA Cancer J Clin, 49, 8, 10.3322/canjclin.49.1.8 Illiopoulos, 2000, Genetic and clinical aspects of familial renal neoplasms, Sem Oncol, 27, 138 Área de Epidemiología Ambiental y Cáncer. Centro Nacional de Epidemiología. Instituto de Salud Carlos III (2005). La situación del Cáncer en España Madrid: Ministerio de Sanidad y Consumo. Long, 1994, The use of molecular genetic analysis in the diagnosis of renal cell carcinoma, World J Urol, 12, 69, 10.1007/BF00184239 Latif, 1993, Identification of the von Hippel-Lindau disease tumor suppressor gene, Science, 260, 1317, 10.1126/science.8493574 Linehan, 1996, Identification of the von Hippel-lindau (VHL) gene. Its role in renal cancer, JAMA, 273, 564, 10.1001/jama.1995.03520310062031 Igarashi, 2002, Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma, Cancer, 95, 47, 10.1002/cncr.10635 Ortiz Gorraiz, 2005, Valoración de factores pronósticas de la supervivencia en una serie de 202 pacientes intervenidos por carcinoma de células renales, Actas Urol Esp, 29, 179, 10.1016/S0210-4806(05)73221-6 Fuhrman, 1982, Prognostic significance of morphologic parameters in renal cell carcinoma, Am J Surg Pathol, 6, 655, 10.1097/00000478-198210000-00007 Guinan P, et al. TNM Staging of renal cell carcinoma. Workgroup No 3. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:992–93. Algaba, 2004, Handling and pathology reporting of renal tumor specimens, Eur Urol, 45, 437, 10.1016/j.eururo.2003.11.026 Barnabas, 2002, Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma, J Surg Oncol, 80, 52, 10.1002/jso.10086 Mattocks, 2000, Comparative sequence analysis (CSA): A new sequence-based method for the identification and characterization of mutations in DNA, Hum Mutat, 16, 437, 10.1002/1098-1004(200011)16:5<437::AID-HUMU9>3.0.CO;2-Q Sheffield, 1993, The sensitivity of sigle-strand conformation polymorphism analysis for the detection of single base substitutions, Genomics, 16, 325, 10.1006/geno.1993.1193 Gnarra, 1994, Mutations of the VHL tumour suppressor gene in renal carcinoma, Nat Gen, 7, 85, 10.1038/ng0594-85 Shuin, 1994, Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas, Cancer Res, 54, 2852 Foster, 1994, Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma, Hum Mol Genet, 3, 2169, 10.1093/hmg/3.12.2169 Brauch, 2000, VHL alterations in human clear cell renal cell carcinoma: Association with advanced tumor stage and a novel hot spot mutation, Cancer Res, 60, 1942 Hamano, 2002, Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma, J Urol, 167, 713, 10.1016/S0022-5347(01)69132-8 Schraml, 2002, VHL mutations and their correlation with tumor cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma, J Pathol, 196, 186, 10.1002/path.1034 van Houwelingen, 2005, Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from the Netherlands cohort study, BMC Cancer, 5, 57, 10.1186/1471-2407-5-57 Tsutsumi, 2003, VHL tumor suppressor gene: its mutation and protein level in renal cell carcinoma, Oncol Rep, 10, 1357 Martínez, 2000, Role of chromosome 3p12–p21 tumour suppressor genes in clear cell renal cell carcinoma: analysisn of VHL dependent and VHL independent pathways of tumorigenesis, J Clin Pathol: Mol Pathol, 53, 137 Kondo, 2002, Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: Relationship to clinicopathological parameters, Genes Chromosomes Cancer, 34, 58, 10.1002/gcc.10054 Kenck, 1996, Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas, J Pathol, 179, 157, 10.1002/(SICI)1096-9896(199606)179:2<157::AID-PATH557>3.0.CO;2-S Lang, 2004, Prognostic value of multifocality on progression and survival in localizad renal cell carcinoma, Eur Urol, 45, 749, 10.1016/j.eururo.2004.02.006 Yao, 2002, VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma, JNCI, 94, 1569, 10.1093/jnci/94.20.1569